Assembly Biosciences, Inc. (HAM:V7B) Financings

Assembly Biosciences, Inc.

Financings

RaiseDate
Public offering of common stock and pre-funded warrants with accompanying Class A and Class B warrants
Announced: US$19.6 a share · Warrants at US$21.6 for 60 months · Guggenheim Securities +1
Dealers: Guggenheim Securities (lead), Mizuho (co-lead)
Buyers: Commodore Capital; Blackstone Multi-Asset Investing; Farallon Capital Management, L.L.C.; Janus Henderson Investors; RA Capital Management
Use of proceeds: General corporate purposes
Aug 8, 2025
Private placement of common stock with accompanying Class A and Class B warrants
Announced: private placement
Buyers: Gilead Sciences, Inc. (2,295,920 shares of common stock and accompanying Class A and Class B warrants to purchase up to 2,295,920 shares)
Use of proceeds: General corporate purposes
Aug 8, 2025
Strategic investment of common stock
Closed: US$20.1M raised
Buyers: Gilead (approximately $20.1 million equity investment)
Use of proceeds: To advance clinical development programs
Mar 20, 2025

Read by 6ix AI from the company's releases